Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7728114 Anti-CD3 antibodies and methods of use thereof

Patent 7728114 was granted and assigned to Novimmune on June, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
‌
Novimmune
0
Date Filed
June 3, 2005
0
Date of Patent
June 1, 2010
0
Patent Application Number
11145131
0
Patent Citations Received
‌
US Patent 12129309 Heterodimeric antibodies that bind CD3 and CD38
0
‌
US Patent 11970540 Anti-BCMA heavy chain-only antibodies
0
‌
US Patent 11981743 Monoclonal antibody and a method thereof
0
‌
US Patent 12006366 Methods and compositions for preventing type 1 diabetes
0
‌
US Patent 12077586 Bispecific antibodies for use in the treatment of hematological malignancies
0
‌
US Patent 12077595 Single domain antibodies that bind to CD137
0
‌
US Patent 12110328 Single domain antibodies targeting CD1d
0
‌
US Patent 12128093 Methods of treating polycystic kidney disease
0
‌
US Patent 11660340 Combination therapy using T cell redirection antigen binding molecule against cell having immunosuppressing function
0
‌
US Patent 11673972 Heterodimeric antibodies that bind CD3 and tumor antigens
0
•••
Patent Inventor Names
Greg Elson
0
Olivier Leger
0
Yann Dean
0
Bernard Mach
0
Marie Kosco-Vilbois
0
Nicolas Fischer
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7728114
0
Patent Primary Examiner
‌
Ram R. Shukla
0

Find more entities like US Patent 7728114 Anti-CD3 antibodies and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo